Back to the catalog
Spinoff story
NASA Bioreactors Advance Disease Treatments
A real-world story of NASA technology finding a life beyond the mission.
About this technology
Overview
Houston-based biotechnology firm Regenetech Inc. acquired the licenses for NASA bioreactor technology from Johnson Space Center. The NASA bioreactor, which allows for the rapid cultivation of healthy cells in simulated weightlessness, is now the foundation of Regenetech's thriving intellectual property business that is providing researchers with the tools to make adult stem cell therapy-a potential source of treatment for conditions like heart disease, diabetes, and sickle cell anemia-viable for the public.